Synopsis
Synopsis
0
JDMF
0
VMF
0
API
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Finished Drug Prices
NA
1. 232632, Bms
2. 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic Acid Dimethyl Ester
3. Atazanavir
4. Bms 232632
5. Bms 232632 05
6. Bms-232632
7. Bms-232632-05
8. Bms232632
9. Bms23263205
10. Cgp 73547
11. Cgp 75136
12. Cgp 75176
13. Cgp 75355
14. Cgp-73547
15. Cgp-75136
16. Cgp-75176
17. Cgp-75355
18. Cgp73547
19. Cgp75136
20. Cgp75176
21. Cgp75355
22. Reyataz
1. 229975-97-7
2. Reyataz
3. Atazanavir Sulphate
4. Bms-232632-05
5. Atazanavir (sulfate)
6. Atazanavir Sulfate [usan]
7. Atazor
8. Atazanavir So4
9. 4mt4vie29p
10. Atazanavir Sulfate (bms-232632-05)
11. 229975-97-7 (sulfate)
12. Nsc-742546
13. 2,5,6,10,13-pentaazatetradecanedioic Acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, Dimethyl Ester, (3s,8s,9s,12s)-, Sulfate (1:1) (salt)
14. Reyataz (tn)
15. 2,5,6,10,13-pentaazatetradecanedioic Acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((-4-(2-pyridinyl)phenyl)methyl)-, Dimethyl Ester, (3s,8s,9s,12s)-, Sulfate (1:1) (salt)
16. Dimethyl (3s,8s,9s,12s)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate, Sulfate (1:1) (salt)
17. Chebi:31243
18. Smr002544693
19. Atazanavir Bisulfate Salt
20. Unii-4mt4vie29p
21. Ulfuric Acid
22. Atazanaviri Sulfas
23. Mls003915641
24. Mls006010199
25. Schembl341700
26. Atazanavir So4 [vandf]
27. Atazanavir Sulfate [mi]
28. Atazanavir Sulfate (jan/usan)
29. Atazanavir Sulfate [jan]
30. Chembl1200678
31. Bms-232632-05, Reyataz
32. Dtxsid401017206
33. Atazanavir Sulfate [mart.]
34. Amy36999
35. Atazanavir Sulfate [usp-rs]
36. Atazanavir Sulfate [who-dd]
37. Atazanavir Sulfate [who-ip]
38. Ex-a4010
39. Methyl N-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;sulfuric Acid
40. Hy-17367a
41. Mfcd08067748
42. S1457
43. Akos016000176
44. Atazanavir Sulphate [ema Epar]
45. Ccg-270493
46. Cs-1890
47. Nsc 742546
48. Atazanavir Sulfate [orange Book]
49. Atazanavir Sulfate [ep Monograph]
50. As-14954
51. Atazanaviri Sulfas [who-ip Latin]
52. Evotaz Component Atazanavir Sulfate
53. Methyl ((5s,10s,11s,14s)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate Sulfate
54. Atazanavir Sulfate Component Of Evotaz
55. Sw220258-1
56. D01276
57. 975a977
58. A816475
59. J-014934
60. 3-amino-3-(3-benzyloxy-phenyl)-propionicacid
61. Q27114238
62. 2,5,6,10,13-pentaazatetradecanedioic Acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((-4-(2-pyridinyl)phenyl)methyl)-, Dimethyl Ester, (3s,8s,9s,12s)-, Sulphate (1:1) (salt)
63. Dimethyl (3s,8s,9s,12s)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate, Sulphate (1:1) (salt)
64. Dimethyl (3s,8s,9s,12s)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-((4-(pyridin-2-yl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioate Monosulfate
65. Methyl N-[(1s)-1-[[(1s,2s)-1-benzyl-2-hydroxy-3-[[[(2s)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[(4-phenylphenyl)methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate; Sulfuric Acid;atazanavir Sulfate
66. Methyl N-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;s
Molecular Weight | 802.9 g/mol |
---|---|
Molecular Formula | C38H54N6O11S |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 18 |
Exact Mass | 802.35712773 g/mol |
Monoisotopic Mass | 802.35712773 g/mol |
Topological Polar Surface Area | 254 Ų |
Heavy Atom Count | 56 |
Formal Charge | 0 |
Complexity | 1190 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Atazanavir sulfate |
Drug Label | REYATAZ (atazanavir sulfate) is an azapeptide inhibitor of HIV-1 protease.The chemical name for atazanavir sulfate is (3S,8S,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pen... |
Active Ingredient | Atazanavir sulfate |
Dosage Form | Capsule |
Route | oral; Oral |
Strength | 300mg; eq 100mg base; 200mg; eq 200mg base; 100mg; eq 300mg base; 150mg; eq 150mg base |
Market Status | Tentative Approval; Prescription |
Company | Matrix Labs; Emcure Pharms; Aurobindo Pharma; Teva Pharms Usa; Emcure Pharma |
2 of 4 | |
---|---|
Drug Name | Reyataz |
PubMed Health | Atazanavir (By mouth) |
Drug Classes | Antiretroviral Agent, Antiviral |
Drug Label | REYATAZ (atazanavir sulfate) is an azapeptide inhibitor of HIV-1 protease.The chemical name for atazanavir sulfate is (3S,8S,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pen... |
Active Ingredient | Atazanavir sulfate |
Dosage Form | Capsule; Powder |
Route | Oral |
Strength | eq 50mg base/packet; eq 150mg base; eq 200mg base; eq 300mg base |
Market Status | Prescription |
Company | Bristol Myers Squibb |
3 of 4 | |
---|---|
Drug Name | Atazanavir sulfate |
Drug Label | REYATAZ (atazanavir sulfate) is an azapeptide inhibitor of HIV-1 protease.The chemical name for atazanavir sulfate is (3S,8S,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pen... |
Active Ingredient | Atazanavir sulfate |
Dosage Form | Capsule |
Route | oral; Oral |
Strength | 300mg; eq 100mg base; 200mg; eq 200mg base; 100mg; eq 300mg base; 150mg; eq 150mg base |
Market Status | Tentative Approval; Prescription |
Company | Matrix Labs; Emcure Pharms; Aurobindo Pharma; Teva Pharms Usa; Emcure Pharma |
4 of 4 | |
---|---|
Drug Name | Reyataz |
PubMed Health | Atazanavir (By mouth) |
Drug Classes | Antiretroviral Agent, Antiviral |
Drug Label | REYATAZ (atazanavir sulfate) is an azapeptide inhibitor of HIV-1 protease.The chemical name for atazanavir sulfate is (3S,8S,9S,12S)-3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pen... |
Active Ingredient | Atazanavir sulfate |
Dosage Form | Capsule; Powder |
Route | Oral |
Strength | eq 50mg base/packet; eq 150mg base; eq 200mg base; eq 300mg base |
Market Status | Prescription |
Company | Bristol Myers Squibb |
Reyataz capsules, co-administered with low dose ritonavir, are indicated for the treatment of HIV-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products (see section 4. 2).
Based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors ( 4 PI mutations).
The choice of Reyataz in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patients treatment history (see sections 4. 4 and 5. 1).
Reyataz oral powder, co-administered with low dose ritonavir, is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected paediatric patients at least 3 months of age and weighing at least 5 kg (see section 4. 2).
Based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors ( 4 PI mutations). The choice of Reyataz in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patients treatment history (see sections 4. 4 and 5. 1).
HIV Protease Inhibitors
Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)
J05AE08
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?